These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29194460)

  • 21. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.
    Distler E; Bloetz A; Albrecht J; Asdufan S; Hohberger A; Frey M; Schnürer E; Thomas S; Theobald M; Hartwig UF; Herr W
    Haematologica; 2011 Jul; 96(7):1024-32. PubMed ID: 21486863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
    Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
    Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect on the proliferation and apoptosis of alloreactive T cells of cell dose in a murine MHC-mismatched hematopoietic cell transplantation model.
    Fujioka T; Taniguchi Y; Masuda T; Nishida S; Ikegame K; Kawakami M; Tsuboi A; Hosen N; Murakami M; Oji Y; Oka Y; Sugiyama H; Kawase I; Ogawa H
    Transpl Immunol; 2003; 11(2):187-95. PubMed ID: 12799203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives.
    Li Pira G; Di Cecca S; Montanari M; Moretta L; Manca F
    Blood Rev; 2016 Jul; 30(4):297-307. PubMed ID: 27066851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II.
    van Balen P; van Bergen CAM; van Luxemburg-Heijs SAP; de Klerk W; van Egmond EHM; Veld SAJ; Halkes CJM; Zwaginga JJ; Griffioen M; Jedema I; Falkenburg JHF
    Front Immunol; 2018; 9():3016. PubMed ID: 30619360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.
    Larsen ME; Kornblit B; Larsen MV; Masmas TN; Nielsen M; Thiim M; Garred P; Stryhn A; Lund O; Buus S; Vindelov L
    Biol Blood Marrow Transplant; 2010 Oct; 16(10):1370-81. PubMed ID: 20353833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency of cytotoxic and helper T-lymphocyte precursors in donors with alloreactivity to recipient histocompatibility antigens. Possible use in predicting acute graft vs host disease in bone marrow transplantation].
    Cukrová V; Dolezalová L; Loudová M; Vítek A; Starý J
    Cas Lek Cesk; 1997 Feb; 136(3):80-4. PubMed ID: 9221174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering.
    Scheinberg P; Price DA; Ambrozak DR; Barrett AJ; Douek DC
    Exp Hematol; 2006 Jun; 34(6):788-95. PubMed ID: 16728284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens.
    Lansford JL; Dharmasiri U; Chai S; Hunsucker SA; Bortone DS; Keating JE; Schlup IM; Glish GL; Collins EJ; Alatrash G; Molldrem JJ; Armistead PM; Vincent BG
    Blood Adv; 2018 Aug; 2(16):2052-2062. PubMed ID: 30115642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of in vitro alloreactive T-cell functional tests in the selection of HLA matched and mismatched haematopoietic stem cell donors.
    Jeras M
    Transpl Immunol; 2002 Aug; 10(2-3):205-14. PubMed ID: 12216951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A; Solomon SR
    Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.
    Nishida T; Akatsuka Y; Morishima Y; Hamajima N; Tsujimura K; Kuzushima K; Kodera Y; Takahashi T
    Br J Haematol; 2004 Mar; 124(5):629-35. PubMed ID: 14871250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency analysis of cytotoxic T lymphocyte precursors--possible relevance to HLA-matched unrelated donor bone marrow transplantation.
    Kaminski E; Sharrock C; Hows J; Ritter M; Arthur C; McKinnon S; Batchelor JR
    Bone Marrow Transplant; 1988 Mar; 3(2):149-55. PubMed ID: 3048479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients.
    Bestard O; Nickel P; Cruzado JM; Schoenemann C; Boenisch O; Sefrin A; Grinyó JM; Volk HD; Reinke P
    J Am Soc Nephrol; 2008 Jul; 19(7):1419-29. PubMed ID: 18417724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.
    Amir AL; van der Steen DM; Hagedoorn RS; Kester MG; van Bergen CA; Drijfhout JW; de Ru AH; Falkenburg JH; van Veelen PA; Heemskerk MH
    Blood; 2011 Dec; 118(26):6733-42. PubMed ID: 21972290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.